Clinical Trial Research Updates

Weekly plain-language updates on clinical trial activity, written for patients and caregivers. TrialsAlert publishes research updates every Friday covering the most notable trials across all monitored conditions.

What are clinical trial research updates?

Clinical trial research updates are weekly summaries of new and updated clinical trials published on ClinicalTrials.gov, the world's largest registry of clinical studies. Each update covers a specific medical specialty or condition, highlighting the most significant trials from the past week. Our AI scores each trial across six dimensions — phase importance, breakthrough potential, patient accessibility, condition prevalence, sponsor credibility, and relevance — then classifies them as breakthrough, notable, or routine. The resulting briefings explain what changed, who is sponsoring the research, what phase it is in, and why it matters for patients, all in plain English without medical jargon. These updates serve patients, caregivers, and support communities who want to stay informed about clinical research without spending hours searching databases themselves.

Recent Updates

Immunology Clinical Trials Update: Week 33, 2026

August 14, 2026 — 5 trials covered | Immunology

A Randomized, Double-Blind, Placebo-Controlled, Multi-Centre Study to Assess the Efficacy of PURETHAL Mites Mixture 50,000 AUeq/mL Subcutaneous Immunotherapy in Adult Subjects With Moderate to Severe ...

Rare Diseases Clinical Trials Update: Week 33, 2026

August 14, 2026 — 5 trials covered | Rare Diseases

Mapping Disease Pathways for Biliary Atresia This study by the University of Pittsburgh is exploring the genetic and developmental causes of biliary atresia, a serious liver condition that affects new...

Urology Clinical Trials Update: Week 33, 2026

August 14, 2026 — 5 trials covered | Urology

REtrieval of Transurethrally Resected Intact En-bloc Vesical Tumors Using a Retrieval Device for Bladder Tumors This study is testing a new device called CURTIS designed to help remove bladder tumors ...

Autoimmune & Rheumatology Clinical Trials Update: Week 33, 2026

August 14, 2026 — 5 trials covered | Autoimmune & Rheumatology

A Study of Outcomes in Chinese Patients Treated With Anifrolumab Who Have Active Mod-severe Systemic Lupus Erythematosus This Phase 3 study is exploring the use of anifrolumab, an immunotherapy, in Ch...

Eye Disease & Ophthalmology Clinical Trials Update: Week 33, 2026

August 14, 2026 — 5 trials covered | Eye Disease & Ophthalmology

South Asian Patients With Diabetic Macular Oedema Treated With Faricimab Assessing the Efficacy, Durability, and Safety (SEAFAR Study) This Phase 4 trial is focusing on faricimab injections for South ...

Kidney Disease & Nephrology Clinical Trials Update: Week 33, 2026

August 14, 2026 — 5 trials covered | Kidney Disease & Nephrology

A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease This Phase III trial is testing elecoglipron, an oral medication, to see if it...

Skin Conditions & Dermatology Clinical Trials Update: Week 33, 2026

August 14, 2026 — 5 trials covered | Skin Conditions & Dermatology

A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis on Background Topical Corticosteroids This Pha...

Pediatrics & Child Health Clinical Trials Update: Week 33, 2026

August 14, 2026 — 5 trials covered | Pediatrics & Child Health

Evaluating Treatment of ADHD in Children With Down Syndrome This Phase 4 study is looking at how well a stimulant medication works for children who have both Down syndrome and ADHD. Since children wit...

Women's Health & Gynecology Clinical Trials Update: Week 33, 2026

August 14, 2026 — 5 trials covered | Women's Health & Gynecology

Oral Azithromycin to Prevent Stillbirths and Infant Mortality in Mali This large Phase 4 trial is testing whether giving oral azithromycin to pregnant women and their infants can reduce the number of ...

Lung & Respiratory Disease Clinical Trials Update: Week 33, 2026

August 14, 2026 — 5 trials covered | Lung & Respiratory Disease

A Study to Evaluate the Efficacy and Safety of QVM149 Versus Salmeterol Xinafoate/Fluticasone Propionate in Children From 12 Years to Less Than 18 Years of Age With Asthma This Phase 3 study is testin...

Diabetes & Endocrinology Clinical Trials Update: Week 33, 2026

August 14, 2026 — 5 trials covered | Diabetes & Endocrinology

A Research Study Comparing RYBELSUS® to Other Blood Sugar Lowering Tablets in People Living in America With Type 2 Diabetes (REALYSE) This large study tested the oral medication RYBELSUS® against othe...

Infectious Disease Clinical Trials Update: Week 33, 2026

August 14, 2026 — 5 trials covered | Infectious Disease

A Study to Learn About BNT162b2 (LP.8.1)-Adapted Vaccine Against SARS-CoV-2 in Children 5 Through 11 Years of Age That Are Considered at Higher Risk of Severe COVID-19 This Phase 3 trial tested an upd...

Blood Disorders & Hematology Clinical Trials Update: Week 33, 2026

August 14, 2026 — 5 trials covered | Blood Disorders & Hematology

Umbilical Cord Blood Consolidation for Older Adults With Intermediate- and High-Risk AML This Phase 3 trial is studying whether adding umbilical cord blood infusions to chemotherapy can help older adu...

Heart Disease & Cardiology Clinical Trials Update: Week 33, 2026

August 14, 2026 — 5 trials covered | Heart Disease & Cardiology

A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF This Phase III study is testing elecoglipron, a new medication, in adults with hea...

Orthopedics & Musculoskeletal Clinical Trials Update: Week 33, 2026

August 14, 2026 — 5 trials covered | Orthopedics & Musculoskeletal

Effect of peRiopErative duLoxetIne Administration on Opioid Consumption Following Total kneE Arthroplasty (RELIFE) This study is exploring whether duloxetine, a medication often used for nerve pain an...

Mental Health & Psychiatry Clinical Trials Update: Week 33, 2026

August 14, 2026 — 5 trials covered | Mental Health & Psychiatry

A Clinical Trial Evaluating Fecal Microbiota Transplantation (FMT) in Adolescents With ADHD This phase 2 study is exploring a new approach for treating adolescents aged 13 to 17 with ADHD by using ora...

Neurology & Brain Disorders Clinical Trials Update: Week 33, 2026

August 14, 2026 — 5 trials covered | Neurology & Brain Disorders

A Study to Learn About the Long-Term Safety of Higher Doses of Nusinersen (BIIB058) Given as Injections to Participants With Spinal Muscular Atrophy (SMA) Who Took Part in an Earlier Nusinersen Trial ...

Rare Diseases Clinical Trials Update: Week 32, 2026

August 7, 2026 — 4 trials covered | Rare Diseases

Stem Cell Gene Therapy for Cystinosis This Phase 1/2 trial led by the University of California, San Diego explored a new gene therapy approach for cystinosis, a rare genetic disorder that affects how ...

Immunology Clinical Trials Update: Week 32, 2026

August 7, 2026 — 5 trials covered | Immunology

Randomized Stepped Wedge Study of Emapalumab in APECED Enteritis This Phase 2 trial is investigating emapalumab as a treatment for APECED enteritis, a rare autoimmune condition where the immune system...

Urology Clinical Trials Update: Week 32, 2026

August 7, 2026 — 5 trials covered | Urology

Active Surveillance Versus Adjuvant Intravesical Chemotherapy in Liquid Biopsy-Defined Low-Shedding Intermediate-Risk NMIBC This trial is exploring whether some patients with intermediate-risk non-mus...

Autoimmune & Rheumatology Clinical Trials Update: Week 32, 2026

August 7, 2026 — 5 trials covered | Autoimmune & Rheumatology

A Study of the Efficacy and Safety of SHR-1314 for Adult Active Psoriatic Arthritis This Phase III trial is testing a new injection called SHR-1314 for adults with active psoriatic arthritis, a condit...

Kidney Disease & Nephrology Clinical Trials Update: Week 32, 2026

August 7, 2026 — 5 trials covered | Kidney Disease & Nephrology

FXS6837 for the Treatment for IgAN Patients(Longterm Study) This Phase 2 study is testing the long-term safety and effectiveness of FXS6837 capsules in patients with primary IgA nephropathy, a common ...

Eye Disease & Ophthalmology Clinical Trials Update: Week 32, 2026

August 7, 2026 — 5 trials covered | Eye Disease & Ophthalmology

A Phase 2 Efficacy and Safety Study of GAL-101, 2% Ophthalmic Solution in Non-foveal Geographic Atrophy Secondary to Non-neovascular AMD This Phase 2 trial is testing GAL-101 eye drops for patients wi...

Skin Conditions & Dermatology Clinical Trials Update: Week 32, 2026

August 7, 2026 — 5 trials covered | Skin Conditions & Dermatology

A Study Assessing Rocatinlimab in Combination With Topical Corticosteroid and/or Topical Calcineurin Inhibitors in Adult Participants With Moderate-to-severe Atopic Dermatitis (AD) This Phase 3 study ...

Lung & Respiratory Disease Clinical Trials Update: Week 32, 2026

August 7, 2026 — 5 trials covered | Lung & Respiratory Disease

ARrest RESpiraTory Failure From PNEUMONIA This Phase 3 trial tested an inhaled combination treatment for patients hospitalized with pneumonia who had low oxygen levels. The treatment aimed to prevent ...

Infectious Disease Clinical Trials Update: Week 32, 2026

August 7, 2026 — 5 trials covered | Infectious Disease

Azithromycin for Child Survival in Niger: Mortality and Resistance Trial This Phase 4 trial tested giving azithromycin to children under five years old in Niger every six months. The goal was to see i...

Women's Health & Gynecology Clinical Trials Update: Week 32, 2026

August 7, 2026 — 5 trials covered | Women's Health & Gynecology

Bupropion for the Prevention of Postpartum Smoking Relapse A Phase 4 trial led by the University of Minnesota tested whether the medication bupropion can help new mothers avoid starting smoking again ...

Blood Disorders & Hematology Clinical Trials Update: Week 32, 2026

August 7, 2026 — 5 trials covered | Blood Disorders & Hematology

A Study Comparing a New Drug (Surovatamig) With Standard Radiotherapy With or Without Rituximab in Adults With Limited Stage Nodal Follicular Lymphoma This upcoming phase 3 trial will compare a new dr...

Subscribe to get weekly briefings for your specific condition.